This is unique to Hers versus Ros GLP-1-only approach
The quite unexpected positive cardiorenal outcomes that have emerged from the cardiovascular outcomes trials (CVOTs) with both glucagon like peptide-1 receptors agonists (GLP-1RA) and sodium-glucose co-transporter 2 (SGLT-2) inhibitors have produced a shift of diabetes management from the meticulous glycemic control alone to the simultaneous improvement of CV outcomes
If you want to track those changes without guessing, download the PeptIQ app and log your dose, cravings, weight trend, and notes in one place
doi: 10.1016/j.ejpb.2012.12.009 437 ZahiriMBabaeiMAbnousKTaghdisiSMRamezaniMAlibolandiM
The decision to have surgery felt risky and self-indulgent, and I approached it with a kind of secrecy that made it feel illicit, as though I were doing something wrong, or at least something I needed to protect and justify
Caveat common to all fecal microbiota studies , not just this one: Fecal samples mostly represent distal colon microbiota